NCT00646204View on ClinicalTrials.gov

Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions

Parkinson's Disease

Interventions

DRUG

Memantine

10 mg bid

DRUG

placebo

2 tabs bid

Trial Locations (1)

77030

PDCMDC 6550 Fannin, Suite 1801, Houston

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Baylor College of Medicine

OTHER